AAOS: Flexor hallucis longus augmentation in the treatment of Achilles tendinopathy .
Flexor Hallucis Longus Transfer for Insertional Achilles Tendinopathy: A Prospective, Randomized Study
44 patients at least 50 years old with chronic insertional Achilles tendinopathy for whom nonoperative treatments have failed, were randomized to Achilles debridement and ostectomy alone or with flexor hallucis longus (FHL) tendon augmentation. The purpose was to determine whether the augmentation would be more effective than the surgery alone. Results at 1 year revealed that although no significant differences were found between groups with respect to clinical outcomes, augmentation with FHL provided significantly greater ankle plantarflexion strength.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
